Company Profile
Alkermes plc Stock Price, News & Catalysts
- Ticker:
- ALKS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Ireland
Stock performance
46.71 USD (+1.39%)
Close
Last updated: September 17, 2026
6.89B USD
Market cap
Why the stock is moving
The latest monitored headline was âAlkermes Announces Appointment of Anne C. Whitaker to Board of Directorsâ. ALKS was little changed in the corresponding trading session, closing at $46.07 on Sep 16, 2026.
Company overview
Business overview
Alkermes is a biopharmaceutical company focused on neuroscience, addiction medicine, and specialty therapeutics. Its portfolio combines commercial products and development programs across CNS and related areas.
Geographic Base and Sector Classification
Alkermes is headquartered in Ireland and listed on NASDAQ. It has a global footprint with a strong U.S. commercial base.
Business Model Characteristics
The company generates value through product sales, neuroscience development, and lifecycle management across a specialty portfolio. Investors watch commercial execution, pipeline progress, and strategic allocation.
Position Within the Biotechnology Landscape
Alkermes sits in the upper tier of specialty neuroscience biotech. It is more durable than a pure development-stage name, but catalyst events still matter to the story.
Future catalysts
- Alkermesâ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the companyâs growth mix. Investors will watch whether the commercial base stays durable.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Alkermes plc (ALKS)?
Alkermes plc (ALKS) most recently closed at 46.71 USD, a +1.39% move versus the previous session.
What is the market cap of Alkermes plc (ALKS)?
Alkermes plc currently has a market capitalization of 6.89B USD on BioPharmSignal.
What does Alkermes plc do?
Alkermes is a biopharmaceutical company focused on neuroscience, addiction medicine, and specialty therapeutics. Its portfolio combines commercial products and development programs across CNS and related areas.
On which exchange is ALKS stock listed?
Alkermes plc (ALKS) is associated with NASDAQ, Ireland, Biopharma.
What is Alkermes?
Alkermesâ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the companyâs growth mix.
Which conditions is Alkermes plc targeting with Alkermes?
Alkermes plc is associated with neuroscience based on its company overview and current catalyst commentary.
How does Alkermes plc describe recent progress with Alkermes?
Alkermesâ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the companyâs growth mix.
What is Lybalvi?
Alkermesâ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the companyâs growth mix.